Lamassu Pharma, LLC
Pharmaceutical company · Durham, North Carolina, United States
Lamassu Pharma, LLC is a pharmaceutical company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2018. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $3.3 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $2.7 million sold in a notice filed in 2020.
Lamassu Pharma at a glance
What does Lamassu Pharma do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $3.3 million in total (2020 to 2024). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.7 million sold (2020).
Frequently asked questions about Lamassu Pharma
Where is Lamassu Pharma headquartered?
Lamassu Pharma, LLC is headquartered in Durham, North Carolina, United States.
What does Lamassu Pharma do?
Lamassu Pharma, LLC is a pharmaceutical company.
When was Lamassu Pharma founded?
The earliest incorporation on record for Lamassu Pharma, LLC is in 2018, according to public company registers.
Similar companies
- Opus Genetics, Inc.Durham, North Carolina, United States
- Polarean, Inc.Durham, North Carolina, United States
- T3D Therapeutics, Inc.Durham, North Carolina, United States
- Chimerix IncDurham, North Carolina, United States
- LadeRx, LLCDurham, North Carolina, United States
- BioMarck Pharmaceuticals LtdDurham, North Carolina, United States
- G1 Therapeutics, Inc.Durham, North Carolina, United States
- Satsuma Pharmaceuticals, Inc.Durham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences